Therapeutic aerosols 2-Drugs available by the inhaled route
Inhalation treatment can be said to have stood the test of time, since records can be traced back several thousand years. In ancient Greece, Hippocrates employed the inhalation of vapours distilled in a pot, the lid of which was pierced by a reed;' sulphur and arsenic were said to have been used. The patient breathing these hot vapours needed protection with moistened sponges to avoid scalding. The popularity of these inhalation procedures has waxed and waned, as Miller' writes-at times they have been over praised and unwisely used, and at other times unreasonably condemned and virtually abandoned. The latter phrase still applies to some extent today.
Until the middle of the present century, inhalation treatment with volatile aromatic substances with a mild irritant action such as menthol, thymol, and eucalyptus and smokes derived from burning various types of plant leaf, notably Atropa belladonna and Datura strammonium, was quite commonly recommended for disorders of the upper and lower airways. Several present day pharmaceuticals used for respiratory treatment have been derived from ancient remedies2-for example, khellin was the predecessor of cromoglycate, while burning Datura strammonium leaves form the basis of the asthma cigarette, which is still available from herbalists.
These substances have been largely replaced by the range of modern pharmaceuticals available for inhalation either from a metered dose inhaler (MDI), dry powder inhaler, or nebuliser or for the nose by nasal spray. Although the MDI is the most popular method of administering bronchodilator and corticosteroid aerosols, the nebuliser has the great merit of flexibility-virtually any drug solution or suspension can be nebulised. Most medicinal waters with an increased mineral content at some European spas is not supported by any objective evidence of its efficacy. Fortunately, only a tiny amount (about 10%) of the nebulised water will enter the lungs and it is probably harmless. This is not to deny that a water aerosol may be a useful means of humidifying the inspired air. Here a word of caution is needed. With some ultrasor.ic nebulisers the volume of inhaled water might be such as to cause pulmonary oedema. Isotonic fluid such as saline should be used if the inhaled liquid volume is more than a few millilitres.
Saline aerosol is bland and may well improve mucociliary clearance, particularly in a hypertonic concentration (7-1 %), when it facilitates expectoration.49 It may liquefy sputum by enhancing chloride (and water) flux across the bronchial mucosa. 50 Mucolytic aerosols are also widely used. N-acetylcysteine (Airbron) is the best known in Britain and 2 mercaptoethane sulphonate (Mistabron) in Europe.5' Mistabron appeared to enhance mucociliary clearance in patients with chronic bronchitis,52 although the results did not quite reach statistical significance-a feature of so many studies of mucolytics. In patients with cystic fibrosis, however, inhaled Mistabron significantly improved respiratory function, although there was no change in cough frequency, sputum volume, or the frequency of antibiotic prescriptions compared with the pretreatment period.53 Antihistamines Antihistamines have rarely been given as aerosols since they are said to have no effect in asthma.
Recently, however, two inhaled H, receptor antagonists (clemastine and chlorpheniramine) have been shown to have a bronchodilator effect in asthmatic children54 and clemastine aerosol can prevent exercise induced asthma.55 Inhalation may permit a greater quantity of drug to reach the lungs than is possible after oral administration without giving rise to undesirable side effects, notably sedation,56 and antihistamine aerosols should perhaps be reconsidered.
Antibiotics
The value of antibiotic aerosols in respiratory tract infections has been questioned in the past Inhaled drugs for systemic treatment Some drugs are rapidly absorbed virtually unchanged through the mucosa of the upper airways into the systemic circulation. Others if soluble may be absorbed from the lower airways and alveoli. Glyceryl trinitrate and ergotamine, for example, are both prepared as MDIs and sprayed into the buccal cavity for rapid absorption and control of angina and migraine respectively. As an example of absorption from the lower airways and alveoli, the use of heparin by inhalation has been proposed for systemic anticoagulation. 73 Absorption through the nasal mucosa is also possible. Nebulised insulin is rapidly absorbed via the nose in dogs, particularly when dissolved in a relatively acid medium; and it has been suggested that this would be a simple and painless method of long term treatment in diabetes. 74 Nicotine given either as a liquid spray or as snuff has been used as a substitute for smoking. The use of a nicotine MDI has also been suggested as a means of enabling smokers to obtain nicotine75 without having to inhale more harmful components of tobacco smoke, though whether this would replace cigarettes is dubious. These examples stimulate us to consider how other drugs could be inhaled for their systemic effect, offering the potential advantages of a simple route of administration and rapid onset of action.
Aerosol treatment has undoubtedly come a long way in the past two decades. The waxing and waning of popularity referred to by Miller' almost certainly reflected the lack of understanding of the principles of aerosol treatment. The recent surge of interest has been generated by the application of scientific 6 method to the physical, pharmacological, and clinical problems associated with their use. Some of the problems have now been solved and aerosol treatment is on a much firmer scientific basis. STEWART 
